REV1–DHX36 Control of G-Quadruplex Replication

G-quadruplexes (G4s) are structured, guanine-rich DNA elements that can obstruct replication forks and threaten genome stability. The reference study, Human REV1 interacts with DHX36 to promote replication and tolerance of G-quadruplex DNA, addresses a central unresolved question: how does a replication fork coordinate G4 unwinding with continued DNA synthesis and control of the single-stranded DNA gaps that arise during bypass?

Study Background and Research Question

G4 structures are not simply passive obstacles. Their repetitive sequence composition, alternative folding patterns, stability, and susceptibility to guanine oxidation can interfere with polymerase movement and increase the risk of incomplete or inaccurate replication. Cells therefore rely on several complementary processes, including helicase-mediated resolution, specialized DNA polymerases, and mechanisms that tolerate discontinuities until the fork or post-replicative repair machinery can complete synthesis.

REV1 is a Y-family DNA polymerase with both catalytic and non-catalytic functions. Although its nucleotide-insertion activity is unusual because it uses a protein-template-directed mechanism, its broader importance often derives from its role as a scaffold for recruiting translesion synthesis factors. Earlier work also implicated REV1 in replication near G4 sites and in cooperation with the FANCJ helicase. The new study extends this framework by examining whether REV1 directly coordinates with DHX36, a helicase specialized for G4 recognition and unwinding.

The research question was therefore mechanistic rather than merely descriptive: does REV1 organize a functional G4-tolerance module, and if so, how does its interaction with DHX36 influence fork elongation, strand-specific mutagenesis, gap suppression, and cellular responses to stabilized G4 DNA?

Key Innovation from the Reference Study

The principal innovation is the identification of a direct physical and functional connection between the C-terminal domain of REV1 and DHX36. The study defines a previously uncharacterized REV1-interacting region at the C-terminus of DHX36, moving the REV1–DHX36 relationship beyond genetic or pathway-level association. This domain-level result provides a molecular explanation for how a scaffold associated with specialized polymerases can be coupled to a G4-resolving helicase.

The work also proposes a two-tier model of REV1 action. In the first tier, REV1 helps position or coordinate DHX36-dependent G4 unwinding with the DNA synthesis machinery. In the second, REV1 contributes to suppression of persistent single-stranded DNA gaps generated when replication encounters a stabilized G4. This model explains why REV1 loss affects both fork progression and the quality of replication intermediates, rather than producing only a defect in polymerase recruitment.

A further conceptual advance is the observation that prolonged G4 stabilization can uncouple REV1 from DHX36. Under these conditions, DHX36 accumulates at a site distal from REV1 and the DNA synthesis machinery. The result suggests that G4 tolerance is dynamic: an initially coordinated response can become spatially disorganized when the obstacle persists.

Methods and Experimental Design Insights

The study combines cellular, replication, signaling, and biochemical approaches to connect molecular interaction with genome-scale consequences. REV1-proficient and REV1-deficient contexts were used to determine how loss of the scaffold changes replication behavior. Pyridostatin (PDS) served as a G4-stabilizing perturbation, allowing the investigators to distinguish basal G4 tolerance from responses to a persistent structural barrier.

Fork elongation experiments evaluated whether replication remained dependent on the normal REV1-associated pathway or switched to a PrimPol-driven mechanism after REV1 loss. Additional assays examined the suppression of single-stranded DNA gaps following G4 stabilization. The strand-specific design was important because leading- and lagging-strand synthesis encounter G4 structures in different replication contexts and may recruit different bypass solutions.

The authors also assessed mutagenic G4 replication on the leading and lagging strands. This enabled separation of three related but distinct phenotypes: the ability to continue synthesis, the accuracy of bypass, and the sensitivity of the bypass process to G4 stabilization. Cellular G4 signal measurements and analysis of ATM/ATR pathway activation were used to determine whether defective tolerance translated into increased structural stress and DNA damage response signaling.

Finally, interaction studies tested whether REV1 and DHX36 associate directly rather than only through other replication proteins. Domain-mapping experiments localized the relevant regions to the REV1 C-terminal domain and a newly defined C-terminal region of DHX36. The combination of loss-of-function, chemical stabilization, strand-specific replication, signaling, and protein-interaction assays is a strength because it links phenotype to mechanism.

Protocol Parameters

• G4 perturbation: Use pyridostatin as the experimental condition for stabilizing G4 DNA; interpret responses against a matched untreated or vehicle-controlled condition.
• REV1 comparison: Analyze REV1-proficient and REV1-deficient cells in parallel so that changes in fork progression, gap suppression, and signaling can be attributed to REV1 status.
• Replication readouts: Measure fork elongation and distinguish leading-strand from lagging-strand bypass whenever the experimental system permits strand-specific analysis.
• Gap analysis: Include a readout of single-stranded DNA gaps after G4 stabilization rather than relying only on bulk replication or viability measurements.
• Mechanistic validation: Pair cellular phenotypes with protein-interaction or domain-mapping experiments to test whether REV1–DHX36 association is direct and which regions are required.
• Signaling interpretation: Monitor nuclear G4 accumulation together with ATM/ATR activation, while treating these measurements as indicators of replication-associated stress rather than as a complete description of DNA lesion chemistry.

Core Findings and Why They Matter

REV1 loss redirects fork elongation

Loss of REV1 switched fork elongation toward a PrimPol-driven mechanism. This finding indicates that cells can invoke an alternative synthesis program when the normal REV1-associated coordination system is absent. However, pathway substitution did not fully restore replication quality: REV1-deficient cells showed defective suppression of single-stranded DNA gaps after PDS exposure.

The distinction is important for interpreting replication assays. A cell may preserve some measure of fork movement while accumulating discontinuities that later activate checkpoint pathways or increase genome instability. Thus, fork speed or completion alone may underestimate the consequences of disrupting REV1.

G4 bypass is strand-context dependent

Mutagenic G4 replication on the leading strand was more strongly affected by REV1 loss than the corresponding lagging-strand process. In contrast, only lagging-strand mutagenesis was sensitive to PDS. These results argue against a single universal G4-bypass pathway. The replication-strand context influences whether REV1 is required, whether mutagenesis occurs, and whether stabilizing the G4 structure further changes the outcome.

For experimental design, this means that aggregate mutation measurements can conceal meaningful asymmetry. Studies of G4 tolerance should specify the template-strand context and separate baseline bypass from the response to G4 stabilization.

REV1 deficiency amplifies structural stress signaling

REV1-deficient cells accumulated more nuclear G4 signal, displayed stronger ATM/ATR signaling, and were more sensitive to G4-stabilizing agents. Together, these observations support a model in which REV1 helps limit the persistence or mislocalization of difficult-to-replicate structures. When that function is lost, unresolved G4 DNA and associated replication gaps create a stronger DNA damage response environment.

Importantly, ATM/ATR activation in this study is best interpreted as a consequence of replication stress and genome maintenance failure. It does not by itself establish that all observed lesions are classical DNA double-strand breaks or that ATM inhibition would phenocopy REV1 loss.

DHX36 is functionally coupled to REV1

The direct REV1–DHX36 interaction provides the mechanistic core of the paper. REV1 is positioned not only as a recruitment scaffold for specialized polymerases but also as a regulator that restrains PrimPol activity while coordinating helicase-dependent G4 resolution. Prolonged G4 stabilization disrupts this arrangement, with DHX36 accumulating away from REV1 and the active DNA synthesis machinery.

This spatial uncoupling offers a useful explanation for why persistent G4 stress can become qualitatively different from a transient replication obstacle. The helicase may remain present in the nucleus, yet its separation from the replisome-associated REV1 module could reduce productive G4 bypass and increase the persistence of ssDNA gaps.

Comparison with Existing Internal Articles

The internal article REV1–DHX36 Coordination of G-Quadruplex Replication provides a concise overview of the same study’s central interaction and its relationship to fork progression and ssDNA-gap suppression. The present analysis places that interaction in a broader experimental framework by emphasizing the strand-specific replication results, the PrimPol switch after REV1 loss, and the distinction between transient coordination and prolonged G4-induced uncoupling.

In practical terms, the internal summary is useful for quickly identifying the proposed REV1–DHX36 axis, whereas the reference study is necessary for evaluating how the model is supported by cellular phenotypes, mutagenesis measurements, signaling assays, and domain-level interaction data.

Why this cross-domain matters, maturity, and limitations

The findings are relevant to cancer research because tumor cells frequently operate under replication stress and may depend on specialized tolerance pathways. The observed increase in ATM/ATR signaling and sensitivity to G4-stabilizing agents suggests that REV1–DHX36 status could influence how cells respond to replication-directed interventions. However, this is a mechanistic bridge from genome-integrity biology to therapeutic research, not a demonstrated treatment strategy.

The study did not directly test radiation, glioma, lung cancer, an ATM kinase inhibitor, or clinical response. Therefore, it cannot establish that REV1 deficiency predicts radiosensitization, that ATM inhibition will reproduce the same phenotype, or that the interaction is therapeutically actionable in tumors. These questions require separate experiments using disease-relevant models and carefully matched measurements of G4 burden, replication gaps, checkpoint activation, and cell survival.

Limitations and Transferability

Several limitations should guide interpretation. PDS is a useful experimental tool for increasing G4 persistence, but pharmacological stabilization may not reproduce the structure, genomic distribution, or kinetics of endogenous G4 formation. Results obtained after REV1 loss may also reflect long-term adaptation, including compensatory PrimPol activity, rather than only the immediate function of REV1.

The strand-specific differences further limit simple transferability across cell types. Replication origin usage, helicase abundance, polymerase expression, checkpoint competence, and the genomic distribution of G4 motifs can all alter the balance between bypass and repair. Likewise, increased ATM/ATR signaling is a valuable stress readout but does not resolve the precise lesion types responsible for the phenotype.

Future work should test whether the REV1–DHX36 interaction is dynamically regulated at defined endogenous G4 loci, determine how its disruption affects long-term mutation patterns, and establish whether the same two-tier mechanism operates in primary or tumor-derived systems. These directions follow directly from the study’s evidence without assuming that a pharmacological or clinical application has already been validated.

Research Support Resources

For researchers extending this work into ATM pathway perturbation, AZD1390 (SKU B8328) is a selective ATM kinase inhibitor that can support related DNA damage response, DNA double-strand break repair, and glioblastoma radiosensitization workflows. The product information reports cellular ATM inhibition at an IC50 of 0.78 nM and describes activity as a radiosensitizer for glioma and lung cancer models; these applications were not tested in the REV1–DHX36 study and should be validated in the relevant experimental system.